COVID-19 Vaccine

New Delhi: The Serum Institute of India (SII) today announced that it would produce upto an additional 100 million COVID-19 vaccine doses for India in 2021. A further collaboration among the SII, Gavi and the Bill & Melinda Gates…

ମସ୍କୋ – ରେଗୁଲେଟରୀ ଅଥରିଟି ଅଫ ଇଣ୍ଡିଆର ଅନୁମୋଦନ ପରେ ରୁଷିଆ କୋଭିଡ ଟିକା ସ୍ପୁଟନିକ –ଭି ଭାରତରେ ଡକ୍ଟର ରେଡ୍ଡିସ୍ ଲାବୋରେଟୋରୀକୁ ୧୦୦ ମିଲିଅନ ଡୋଜ୍‌ ଯୋଗାଇବ । ରୁଷିଆ ଖୁବ ଶୀଘ୍ର ଆଂଚଳିକ ଭିତିରେ ଏହିି ଟିକା ବିତରଣ କରିବାକୁ ଲକ୍ଷ ରଖିଛି । ରେଗୁଲେଟୋରୀ ଅଫ୍ ଇଣ୍ଡିଆର ଅନୁମତି…

• AstraZeneca halts coronavirus vaccine trial after volunteer develops ‘unexpected’ illness • Brazil trials of Sinovac COVID-19 vaccine show promising results: governor • CanSino Phase 3 COVID-19 vaccine trial in Pakistan expected to…

Moscow: In a significant development in the global fight against coronavirus, Russia has started releasing ‘Sputnik V’, the world’s first registered COVID-19 vaccine, to the general public, the country’s media reported citing the Health…

New Delhi: India’s first indigenously developed COVID-19 vaccine, COVAXIN is likely to be available by the end of 2020, informed Union Health and Family Welfare Minister Dr Harsh Vardhan. In an interview with Hindustan Times, the Health…

New Delhi: The National Expert Group on Vaccine Administration today met leading domestic vaccine manufactures- Serum Institute of India, Pune; Bharat Biotech, Hyderabad; Zydus Cadila, Ahmedabad; Gennova Biopharmaceuticals, Pune; and…

Bhubaneswar: Human clinical trials of the India’s indigenously developed COVID-19 vaccine will commence in Bhubaneswar from tomorrow. The human clinical trials of COVAXIN, a vaccine developed by Bharat Biotech in collaboration with ICMR,…

New Delhi: The Indian Council of Medical Research (ICMR) has teamed up with Bharat Biotech International Limited (BBIL) to fast-track clinical trials of the indigenous COVID-19 vaccine (BBV152 COVID Vaccine). ICMR Director General Balram…